[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356747-105":59,"doc-detail-356747-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cks1b-is-a-tumor-intrinsic-factor-driving-cd8-t-cell-exhaustion-via-maintaining-persistent-tumor-antigen-stimulation","CKS1B is a tumor-intrinsic factor driving CD8+ T cell exhaustion via maintaining persistent tumor-antigen stimulation","","T cell exhaustion blocks effective antitumor immunity, but tumor-intrinsic drivers remain insufficiently defined. Using single-cell and spatial proteomics in esophageal squamous cell carcinoma (ESCC), the study reveals acute-like and chronic-like CD8+ T cell trajectories shaped by encountered tumor cell subtypes, linking tumor heterogeneity to local immune niches. The tumor-intrinsic protein CKS1B induces chronic-like exhaustion via forming a complex with an S-phase kinase-associated protein, promoting IRF3 ubiquitination and degradation to suppress type I interferon signaling and antigen presentation. Pharmacologic disruption of the CKS1B–IRF3 interaction restores CD8+ function and synergizes with immune checkpoint blockade, supported by conserved oncogenic-immune axis mechanisms across malignancies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cks1b-is-a-tumor-intrinsic-factor-driving-cd8-t-cell-exhaustion-via-maintaining-persistent-tumor-antigen-stimulation/356747/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cks1b-is-a-tumor-intrinsic-factor-driving-cd8-t-cell-exhaustion-via-maintaining-persistent-tumor-antigen-stimulation/356747.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What key question does the paper address about CD8+ T cell exhaustion in tumors?","Question",{"text":113,"@type":114},"It examines whether distinct exhaustion trajectories, resembling acute and chronic infection responses, can coexist within the same tumor and how tumor-intrinsic factors shape them.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the study characterize exhausted CD8+ T cells in the tumor microenvironment?",{"text":118,"@type":114},"It notes high levels of inhibitory receptors such as PD-1 and TIM-3 alongside reduced effector cytokines including IL-2, TNF-α, and IFN-γ.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism is identified as driving chronic-like CD8+ T cell exhaustion?",{"text":122,"@type":114},"CKS1B forms a complex with an S-phase kinase-associated protein to promote IRF3 ubiquitination and degradation, suppressing type I interferon signaling and antigen presentation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356747,1790194181,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","IMMUNOLOGY  \nCKS1B is a tumor-intrinsic factor driving CD8+ T cell exhaustion via maintaining persistent  \ntumor-antigen stimulation  \nSiqi Yu1†, Pujie Wu1†, Xiaoting Xie1, Liang Zhu1, Liping Chen1, YiboYu2, WenTan1, Shaosen Zhang1,3*, Chen Wu1,3,4,5*, Dongxin Lin1,3,4,6*  \nT cell exhaustion is a major barrier to effective antitumor immunity, yet the tumor-intrinsic mechanisms remain poorly defined. Through single-cell and spatial proteomics analyses of esophageal squamous cell carcinoma (ESCC), we uncover two infection-like CD8+ T cell trajectories, acute-like and chronic-like responses, whose fates are dictated by the tumor cell subtypes they encounter. This concept links tumor heterogeneity to the shaping of local immune niches. Mechanistically, we identify CDC28 protein kinase regulatory subunit 1B (CKS1B) as a tumorintrinsic inducer of chronic-like exhaustion. CKS1B forms a complex with S-phase kinase-associated protein to promote interferon regulatory factor 3 (IRF3) ubiquitination and degradation, thereby suppressing type I interferon signaling and antigen presentation. This impairs tumor cell elimination and drives progressive CD8+ T cell stimulation and exhaustion. Pharmacological blockade ofthe CKS1B-IRF3 interaction with 14i restores CD8+ T cell function and synergizes with immune checkpoint blockade. The tumor-intrinsic oncogenic-immune axis, which connects cancer cell signaling to immune dysfunction, is conserved across multiple malignancies, establishing a conceptual and therapeutic framework for overcoming tumor-driven T cell exhaustion.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nT cell exhaustion is a hallmark of chronic infectious diseases and cancer. During acute infections, CD8+ T cells are rapidly activated to clear antigens and subsequently return to a quiescent state; however, in the prolonged chronic infection state, the persisting antigen may sustainedly stimulate CD8+ T cells, leading them to a state of exhaustion ( 1–6) . Cancer may represent a chronic infection–like state where tumor antigens are not able to be fully cleared by the immune system, which can cause exhaustion of infiltrating CD8+ T cells in the tumor microenvironment (TME) . Exhausted CD8+ T cells in TME are characterized by elevated expression of inhibitory receptors such as programmed cell death protein 1 (PD-1) and T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), along with diminished production of effector cytokines including interleukin-2 (IL-2), tumor necrosis factor–α (TNF-α), and interferon-γ(IFN-γ) (7–10) . Beyond tumor antigens, other factors including regulatory CD4+ T cells and myeloid-derived suppressor cells, immunosuppressive cytokines, tumor-derived metabolites, and some other stressors in TME may also contribute to CD8+ T cell exhaustion (9, 11–14) .  \nHowever, whether distinct exhaustion trajectories—akin to acute and chronic infection responses—can coexist within the same tumor remains unknown. Tumors are inherently heterogeneous, composed  \n1department of etiology and carcinogenesis, national cancer center/national clinical Research center for cancer/cancer hospital, chinese Academy of Medical Sciences and Peking Union Medical college, Beijing 100021, china. 2Shenzhen institutes of Advanced technology, chinese Academy of Sciences, Shenzhen 518055, china. 3Key laboratory of cancer Genomic Biology, chinese Academy of Medical Sciences and Peking Union Medical college, Beijing 100021, china. 4collaborative innovation center for cancer Personalized Medicine, nanjing Medical University, nanjing 211166, china. 5cAMS Oxford institute, chinese Academy of Medical Sciences, Beijing 100006, china. 6State Key laboratory of Oncology in South china, SunYat-sen University cancer cent","cbCaipeuLhzZiDE2","https://ap.wps.com/l/cbCaipeuLhzZiDE2","pdf",6451374,21,"English","# Introduction","[{\"question\":\"What key question does the paper address about CD8+ T cell exhaustion in tumors?\",\"answer\":\"It examines whether distinct exhaustion trajectories, resembling acute and chronic infection responses, can coexist within the same tumor and how tumor-intrinsic factors shape them.\"},{\"question\":\"How does the study characterize exhausted CD8+ T cells in the tumor microenvironment?\",\"answer\":\"It notes high levels of inhibitory receptors such as PD-1 and TIM-3 alongside reduced effector cytokines including IL-2, TNF-α, and IFN-γ.\"},{\"question\":\"What mechanism is identified as driving chronic-like CD8+ T cell exhaustion?\",\"answer\":\"CKS1B forms a complex with an S-phase kinase-associated protein to promote IRF3 ubiquitination and degradation, suppressing type I interferon signaling and antigen presentation.\"}]","CKS1B is a tumor-intrinsic factor driving CD8+ T cell exhaustion via maintaining persistent tumor-antigen stimulation | PDF",1790127093,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1768b8878de6dba07c5415a8f377184.webp",983,1250,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6728efffae63e5d46dee92365ff14770.webp",982,1249,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac3263a1e1dc6466aea12fa14b4e7fed.webp",981,1248,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13c50df3c746cf9df55d19192acc35dc.webp",980,1247]